A 5-Question Quiz on Breast Cancer

Article

Do you know the prevalence of triple-negative breast cancer? How about the patient makeup in the START A and START B trials, which tested hypofractionated radiotherapy for breast cancer? Answer these questions and more.

Question 1:

Answer and Question 2 on Next Page »

The correct answer is D. Refer to medical oncologist to discuss an anti-estrogen risk reduction agent (eg, tamoxifen)

Question 2:

Answer and Question 3 on Next Page »

The correct answer is D. Some women with ductal carcinoma in situ were included in these trials

Question 3:

Answer and Question 4 on Next Page »

The correct answer is B. 15% to 20%

Question 4:

Answer and Question 5 on Next Page »

The correct answer is A. The majority of tumors are estrogen-receptor positive

Question 5:

Answer on Next Page »

The correct answer is D. Germline BRCA1- or BRCA2-mutated tumor

 

Newsletter

Stay up to date on recent advances in the multidisciplinary approach to cancer.

Recent Videos
Success with the 177Lu-PSMA-617 radioligand therapy would be transformative for the clear cell renal cell carcinoma treatment landscape.
5 experts are featured in this series
4 experts in this video
2 experts are featured in this series.
4 experts in this video
4 experts in this video
4 experts in this video
2 experts are featured in this series.
Related Content